M

Matricelf Ltd
TASE:MTLF

Watchlist Manager
Matricelf Ltd
TASE:MTLF
Watchlist
Price: 527.3 ILS 0.02%
Market Cap: 145m ILS

Matricelf Ltd
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Matricelf Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
M
Matricelf Ltd
TASE:MTLF
Cash from Operating Activities
-₪11.8m
CAGR 3-Years
-21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Cash from Operating Activities
$28.3m
CAGR 3-Years
19%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Enlivex Therapeutics Ltd
NASDAQ:ENLV
Cash from Operating Activities
-$11.9m
CAGR 3-Years
23%
CAGR 5-Years
-11%
CAGR 10-Years
-1%
Urogen Pharma Ltd
NASDAQ:URGN
Cash from Operating Activities
-$137.7m
CAGR 3-Years
-17%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Cash from Operating Activities
-$7m
CAGR 3-Years
19%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Pluri Inc
NASDAQ:PLUR
Cash from Operating Activities
-$19.6m
CAGR 3-Years
18%
CAGR 5-Years
5%
CAGR 10-Years
1%
No Stocks Found

Matricelf Ltd
Glance View

Market Cap
145m ILS
Industry
Biotechnology

Matricelf Ltd. engages in research and development of technology in the field of regenerative medicine. The firm operates in the field of tissue engineering and regenerative medicine. The Firm develops a platform for autologous 3D printing of neutral human matrix, cells, tissues and organs implants. The implants are manufactured using cellular components originated from the patients themselves, to reduce potential immune response. The firm focuses on the treatment of spinal cord injury (SCI), but is also involved in developing treatment for additional medical conditions, including: Myocardial Infarction (MI), Parkinson’s disease and Age-related Macular Degeneration (AMD). Matricelf Ltd is a spin-out company from Tel Aviv University.

MTLF Intrinsic Value
HIDDEN
Show

See Also

What is Matricelf Ltd's Cash from Operating Activities?
Cash from Operating Activities
-11.8m ILS

Based on the financial report for Dec 31, 2024, Matricelf Ltd's Cash from Operating Activities amounts to -11.8m ILS.

What is Matricelf Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
-21%

Over the last year, the Cash from Operating Activities growth was -12%. The average annual Cash from Operating Activities growth rates for Matricelf Ltd have been -21% over the past three years .

Back to Top